Clinical Trials Browser

Phase 2 × OTHER × efgartigimod alfa × Clear all

NCT06221501 2024-01-24

Perioperative Efgartigimod for Thymoma and Myasthenia Gravis

Phase 2 Not yet recruiting

Myasthenia Gravis